Antihypertensive Drugs Market Size to reach $28,797 million by 2026 and registering a CAGR of 3.1%

Antihypertensive

Antihypertensive

Rise in the geriatric population, surge in healthcare expenditure, and rise in prevalence of hypertension across the globe drive the growth of the global market

Rise in awareness related to treatment of hypertension across the globe is another factor that fuels the growth of the market.”

— Onkar Sumant

PORTLAND, OREGON, UNITED STATES, September 16, 2021 /EINPresswire.com/ — Increase in geriatric population worldwide, rise in healthcare expenditure worldwide, and surge in prevalence of hypertension across the globe have augmented the growth of the global antihypertensive drugs market. Whereas, patent expirations of blockbuster drugs impede the market growth. On the other hand, high growth potential in developing economies is projected to provide lucrative opportunities in the near future.

According to the report, the global antihypertensive drugs industry was pegged at $22.56 billion in 2018 and is projected to reach $28.79 billion by 2026, registering a CAGR of 3.1% from 2019 to 2026.

For Right Perspective and Competitive Insights, Get Sample Report at @

https://www.alliedmarketresearch.com/request-sample/436

Driving factors for the market

Rise in the geriatric population, surge in healthcare expenditure, and rise in prevalence of hypertension across the globe drive the growth of the global antihypertensive drugs market. However, patent expirations of blockbuster drugs hamper the market growth. On the contrary, high growth potential in developing countries is expected to create lucrative opportunities in the near future.

The demand for antihypertensive drugs is on a rise, owing to surge in incidence of hypertension. Furthermore, rise in awareness related to treatment of hypertension across the globe is another factor that fuels the growth of the market.

Based on distribution channel, the market is categorized into retail pharmacy, hospital pharmacy, and e-commerce. The e-commerce websites and online drug stores segment is expected to register the fastest CAGR of 4.2% through 2026. On the other hand, the hospital pharmacy segment accounted for the highest share in 2018, contributing to more than half of the global antihypertensive drugs market.

The hospital pharmacy segment held the largest share

The hospital pharmacy segment dominated the market in 2018, accounting for more than half of the global antihypertensive drugs market, owing to increase in the number of hospitalized NASH patients, surge in number of hospital pharmacies, improvement in structure of hospital pharmacies in the emerging countries such as China and India. However, the e-commerce websites & online drug stores segment is projected to register the fastest CAGR of 4.2% during the study period, due to surge in preference for online purchasing of drugs over the traditional methods, rise in the number of Internet users, and increase in awareness of online pharmacy.

North America dominated the market

The global antihypertensive drugs market across North America held the largest share in 2018, accounting for more than one-third of the market, owing to the availability of the antihypertensive drugs and rise in prevalence of hypertension due to surge in geriatric population in the region. However, the market across the Asia-Pacific region is anticipated to portray the fastest CAGR of 4.2% during the forecast period, owing to surge in awareness related to use of antihypertensive drugs and the presence of active key players in the region.

Enquiry for Short-term and Long-term Impacts of COVID-19 at @

https://www.alliedmarketresearch.com/purchase-enquiry/436

Major market players

Boehringer Ingelheim GmbH
Johnson and Johnson
Merck KGaA
Pfizer, Inc.
Bayer AG
AstraZeneca plc
Takeda Pharmaceutical Co., Ltd.
Sanofi S.A.
Daiichi Sankyo Company
Novartis International AG

Key Findings of the Study:

Calcium channel blockers occupied one-fourths share of the global antihypertensive drugs market in 2018.

The ACE inhibitors segment is anticipated to grow with the highest CAGR throughout the forecast period.

The vasodilators accounted for more than one-fifths share of the market in 2018.

Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

Antihypertensive Drugs Market Research Report 2026 @ https://www.alliedmarketresearch.com/antihypertensives-market

Trending Reports In Healthcare Industry:

Asia Pacific IVD Market – Global Opportunity Analysis and Industry Forecast, 2020-2027

Radiology Information System Market – Global Opportunity Analysis and Industry Forecast, 2020-2027

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 -503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire